Alteration of p16 (CDKN2) gene is associated with interleukin-2-induced tumor cell growth in adult T-cell leukemia. | Exp Hematol;27(6): 1004-9, 1999 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Alteration of p16 (CDKN2) gene is associated with interleukin-2-induced tumor cell growth in adult T-cell leukemia.

Fujiwara, H; Arima, N; Hashimoto-Tamaoki, T; Matsushita, K; Ohtsubo, H; Arimura, K; Hidaka, S; Tei, C.

Affiliation

Fujiwara H; First Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Japan.

Exp Hematol ; 27(6): 1004-9, 1999 Jun.

Article in En | MEDLINE | ID: mdl-10378889

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, T-Cell / Interleukin-2 / Cyclin-Dependent Kinase Inhibitor p16 / Mutation Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Exp Hematol Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, T-Cell / Interleukin-2 / Cyclin-Dependent Kinase Inhibitor p16 / Mutation Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Exp Hematol Year: 1999 Document type: Article Affiliation country: Country of publication: